PJT Partners Inc.
PJTPJT Partners Inc.'s earnings have outrun its stock. EPS grew +35.8% in a year against a −4.3% price move.
The sharpest disagreement: annual EPS moved +35.8% against a −4.3% price move — the market has not yet caught up with the delivery.
The price is topping out (4 weeks in) while the P/BV sits at the 30th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +28.6% year on year, with the the net margin at 21.4%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
PJT Partners Inc. trades at $171, losing momentum at the top and 4 weeks into that stage. That is +6.5% against its own 200-day average. It sits at 71% of a 52-week range of $129 to $188. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks.
Today the stock is losing momentum at the top — week 4 of stage 3. At $171 it trades +6.5% versus its 200-day average and sits at 71% of its 52-week range ($129–$188).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +595% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
PJT Partners Inc. trades at 14.0× P/BV, near the bottom of its own range — cheaper only 30% of the time. Its long-run median P/BV is 16.1×, measured across 5.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 14.0× is near the bottom of its own range — cheaper only 30% of the time, against a long-run median of 16.1× measured over 5.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved −4.3% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +16.7%/yr price move, ~+14.8%/yr came from book-value growth and ~+1.9 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
PJT Partners Inc. reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +47.1% at its peak to +28.0% but is still expanding, ROE lifting at 34.4%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.8% | +18.4% | — | — |
| Profit | +29.2% | +24.7% | — | — |
| EPS | +35.8% | +23.9% | — | — |
| Stock price | −4.3% | +28.5% | +16.7% | +21.6% |
4-Factor Sector Score
50.4/100 — rank 8 of 27 in Capital Markets · 60% evidence confidence
PJT Partners Inc. scores 50.4 out of 100 against the 27 companies it is compared with in Capital Markets, ranking 8. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 20 + 17.4 + 3.5 + 9.5 = 50.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
PJT Partners Inc. reported $0.4 B of income in the Mar 26 quarter, +31.3% year on year. That is the 4th straight quarter of year-on-year growth. Over 4 years it has compounded at 14.6% a year. The last full year, FY25, came in at $1.7 B. The last four reported quarters add to $1.8 B.
FY25 revenue came in at $1.7 B (+14.8% on the year), capping 4 years at 14.6% compound. The latest quarter (Mar 26) printed $0.4 B, +31.3% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +23.5% growth against the decade's 14.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +22.1% over the last 4 quarters against +18.8%/yr over the last 8 — accelerating; TTM profit +28.0% vs +37.2%/yr — rolling over.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
PJT Partners Inc.'s net margin is 21.4% in the Mar 26 quarter, −0.5 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 13.0% to 19.2%. The current quarter is running above every full year in that window.
The latest quarter's net margin is 21.4%, −0.5 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 13.0%–19.2%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
PJT Partners Inc. earned $0.1 B of net profit in the Mar 26 quarter, +28.6% year on year. It is the 9th consecutive quarter of growth. Full-year FY25 profit was $0.3 B. The 4-year compound rate is 13.0%. That is 21.4% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Mar 26 profit was $0.1 B, +28.6% year on year — the 9th consecutive quarter of growth. On the full year, FY25 printed $0.3 B (+29.2%), and the 4-year compound rate is 13.0%.
Why profit moved: revenue contributed +31.3% and the margin −0.5 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +33.7% vs revenue +23.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for PJT Partners Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
PJT Partners Inc.'s revenue grew +14.8% in FY25 to $1.7 B, so the book is growing. The latest quarter ran +31.3% year on year. The net margin on that income is 21.4%, −0.5 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $1.7 B, +14.8% on the year, and the latest quarter ran +31.3% year on year. The net margin on that revenue is 21.4% this quarter (−0.5 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
PJT Partners Inc. earns a return on equity of 31% in FY25. Its trough over the ladder below was 17% in FY23. On the asset side every $100 of the balance sheet earned about $21.10, which is the return before leverage is applied.
FY25 ROE came in at 31%, recovered from a FY23 trough of 17%. On assets, the latest reading is about 21.10% — every $100 the bank deploys earns roughly $21.10 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 13.0% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
PJT Partners Inc. paid $1.00 per share over the last four reported quarters. The most recent declaration was $0.25 for Mar 26. Against the current price of $171 that is a trailing yield of 0.58%, measured on dividends already paid rather than on a forecast.
PJT Partners Inc. paid $1.00 per share across the last four reported quarters, most recently $0.25 for Mar 26. Against the current price of $171 the trailing twelve months work out to 0.58% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
9.7% of PJT Partners Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 4.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 9.7% of the float is sold short, and at typical trading volumes it would take about 4.1 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
PJT Partners Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Marex Group LimitedMRX | 65.0/100Favorable setup76% evidence | LEADER | 24.0/35 Income 32.6% · PAT 40.9% 71% evidence | 12.4/25 ROA 0.6% · ROE 9.4% · GNPA — 68% evidence | 9.5/20 P/BV 2.56× · P/BV÷ROE 0.27 70% evidence | 19.1/20 RS sector 33.4% · RS bench 31.9% · 1Y 81.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 12.4 + 9.5 + 19.1 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Morgan StanleyMS | 63.1/100Mixed-positive evidence80% evidence | LEADER | 21.1/35 Income 18% · PAT 36.8% 81% evidence | 13.7/25 ROA 0.8% · ROE 10.3% · GNPA — 68% evidence | 11.3/20 P/BV 2.27× · P/BV÷ROE 0.22 70% evidence | 17.0/20 RS sector 10.2% · RS bench 9% · 1Y 51.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 13.7 + 11.3 + 17 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Virtu Financial, Inc.VIRT | 63.0/100Mixed-positive evidence60% evidence | LEADER | 14.1/35 Income — · PAT — 26% evidence | 16.8/25 ROA 1.3% · ROE 14.4% · GNPA — 68% evidence | 13.9/20 P/BV 2.21× · P/BV÷ROE 0.15 70% evidence | 18.2/20 RS sector 19.7% · RS bench 18.4% · 1Y 34.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.1 + 16.8 + 13.9 + 18.2 = 63 · Decision use: Price leads the evidence: RS versus the benchmark is 18.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4StoneX Group Inc.SNEX | 62.2/100Mixed-positive evidence62% evidence | FADING | 24.5/35 Income 38% · PAT 56.1% 55% evidence | 13.0/25 ROA — · ROE 7.6% · GNPA — 34% evidence | 8.0/20 P/BV 2.36× · P/BV÷ROE 0.31 70% evidence | 16.7/20 RS sector 22.5% · RS bench 21% · 1Y 89.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 13 + 8 + 16.7 = 62.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5The Charles Schwab CorporationSCHW | 60.9/100Mixed-positive evidence80% evidence | TURNING | 22.8/35 Income 20.3% · PAT 38.6% 81% evidence | 15.6/25 ROA 1.2% · ROE 11.3% · GNPA — 68% evidence | 8.7/20 P/BV 3.32× · P/BV÷ROE 0.29 70% evidence | 13.8/20 RS sector 0.8% · RS bench -0.1% · 1Y 9.5%4 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 15.6 + 8.7 + 13.8 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Piper Sandler CompaniesPIPR | 52.6/100Mixed-positive evidence60% evidence | BASING | 21.7/35 Income — · PAT — 26% evidence | 18.1/25 ROA 7.2% · ROE 10% · GNPA — 68% evidence | 7.0/20 P/BV 3.87× · P/BV÷ROE 0.39 70% evidence | 5.8/20 RS sector -15.8% · RS bench -16.7% · 1Y -5.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 18.1 + 7 + 5.8 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Evercore Inc.EVR | 51.5/100Mixed-positive evidence60% evidence | BASING | 20.9/35 Income — · PAT — 26% evidence | 18.9/25 ROA 6.1% · ROE 11.1% · GNPA — 68% evidence | 5.8/20 P/BV 6.48× · P/BV÷ROE 0.58 70% evidence | 5.9/20 RS sector -12% · RS bench -12.9% · 1Y 8.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 18.9 + 5.8 + 5.9 = 51.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 8PJT Partners Inc.this pagePJT | 50.4/100Mixed-positive evidence60% evidence | TURNING | 20.0/35 Income — · PAT — 26% evidence | 17.4/25 ROA 5% · ROE 8.9% · GNPA — 68% evidence | 3.5/20 P/BV 12.38× · P/BV÷ROE 1.39 70% evidence | 9.5/20 RS sector -5.6% · RS bench -6.6% · 1Y -3%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 17.4 + 3.5 + 9.5 = 50.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 9LPL Financial Holdings Inc.LPLA | 49.4/100Mixed-negative evidence60% evidence | TURNING | 16.4/35 Income — · PAT — 26% evidence | 15.3/25 ROA 2.4% · ROE 7% · GNPA — 68% evidence | 6.4/20 P/BV 3.91× · P/BV÷ROE 0.56 70% evidence | 11.3/20 RS sector -3.6% · RS bench -4.4% · 1Y -4.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 15.3 + 6.4 + 11.3 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10The Goldman Sachs Group, Inc.GS | 48.8/100Mixed-negative evidence80% evidence | BREAKING OUT | 16.8/35 Income 17.8% · PAT 34.8% 81% evidence | 9.2/25 ROA 0.3% · ROE 5.4% · GNPA — 68% evidence | 7.2/20 P/BV 2.03× · P/BV÷ROE 0.38 70% evidence | 15.6/20 RS sector 7.6% · RS bench 6.4% · 1Y 46%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 9.2 + 7.2 + 15.6 = 48.8 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Interactive Brokers Group, Inc.IBKR | 48.0/100Mixed-negative evidence60% evidence | FADING | 16.8/35 Income — · PAT — 26% evidence | 10.8/25 ROA 0.6% · ROE 6.6% · GNPA — 68% evidence | 5.0/20 P/BV 6.57× · P/BV÷ROE 0.99 70% evidence | 15.4/20 RS sector 9.2% · RS bench 8% · 1Y 34.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 10.8 + 5 + 15.4 = 48 · Decision use: Price leads the evidence: RS versus the benchmark is 8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12Stifel Financial Corp.SF | 46.7/100Mixed-negative evidence60% evidence | TURNING | 16.2/35 Income — · PAT — 26% evidence | 8.4/25 ROA -2% · ROE 8.1% · GNPA — 68% evidence | 11.0/20 P/BV 1.9× · P/BV÷ROE 0.23 70% evidence | 11.1/20 RS sector -2.2% · RS bench -3.1% · 1Y 12.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 8.4 + 11 + 11.1 = 46.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Moelis & CompanyMC | 46.6/100Mixed-negative evidence60% evidence | TURNING | 17.5/35 Income — · PAT — 26% evidence | 16.5/25 ROA 3.9% · ROE 8.9% · GNPA — 68% evidence | 4.3/20 P/BV 9.58× · P/BV÷ROE 1.08 70% evidence | 8.3/20 RS sector -6.9% · RS bench -7.8% · 1Y -1.9%4 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 16.5 + 4.3 + 8.3 = 46.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 14Jefferies Financial Group Inc.JEF | 45.1/100Mixed-negative evidence80% evidence | BREAKING OUT | 21.6/35 Income 21.4% · PAT 39.5% 81% evidence | 8.5/25 ROA 0.3% · ROE 2.4% · GNPA — 68% evidence | 6.7/20 P/BV 1.01× · P/BV÷ROE 0.42 70% evidence | 8.3/20 RS sector -8.5% · RS bench -9.5% · 1Y -4.7%9 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 8.5 + 6.7 + 8.3 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15MarketAxess Holdings Inc.MKTX | 45.0/100Mixed-negative evidence60% evidence | TURNING | 15.1/35 Income — · PAT — 26% evidence | 14.8/25 ROA 3.1% · ROE 5.1% · GNPA — 68% evidence | 6.0/20 P/BV 3.26× · P/BV÷ROE 0.64 70% evidence | 9.1/20 RS sector -10.1% · RS bench -10.8% · 1Y -13.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 14.8 + 6 + 9.1 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16TeraWulf Inc.WULF | 44.8/100Thin evidence · provisional55% evidence | FADING | 19.3/35 Income 28% · PAT — 45% evidence | 4.4/25 ROA -4.1% · ROE -897.3% · GNPA — 68% evidence | 9.8/20 P/BV -77.86× · P/BV÷ROE — 10% evidence | 11.3/20 RS sector 7.5% · RS bench 6% · 1Y 275.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 4.4 + 9.8 + 11.3 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17BGC Group, Inc.BGC | 43.9/100Mixed-negative evidence60% evidence | BASING | 16.8/35 Income — · PAT — 26% evidence | 9.2/25 ROA 0.4% · ROE 5.8% · GNPA — 68% evidence | 5.5/20 P/BV 4.63× · P/BV÷ROE 0.8 70% evidence | 12.4/20 RS sector 1.1% · RS bench 0.1% · 1Y 9.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 9.2 + 5.5 + 12.4 = 43.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Tradeweb Markets Inc.TW | 42.5/100Mixed-negative evidence60% evidence | BASING | 18.5/35 Income — · PAT — 26% evidence | 13.8/25 ROA 2.3% · ROE 2.9% · GNPA — 68% evidence | 4.8/20 P/BV 3.17× · P/BV÷ROE 1.09 70% evidence | 5.4/20 RS sector -17.9% · RS bench -18.6% · 1Y -25.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 13.8 + 4.8 + 5.4 = 42.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Riot Platforms, Inc.RIOT | 42.3/100Thin evidence · provisional55% evidence | FADING | 15.3/35 Income 42.3% · PAT — 45% evidence | 4.5/25 ROA -14% · ROE -18.7% · GNPA — 68% evidence | 9.8/20 P/BV 1.96× · P/BV÷ROE — 10% evidence | 12.7/20 RS sector 9.9% · RS bench 8.3% · 1Y 94.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 4.5 + 9.8 + 12.7 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Galaxy Digital Inc.GLXY | 39.7/100Thin evidence · provisional53% evidence | ASLEEP | 22.4/35 Income 25.5% · PAT — 45% evidence | 5.5/25 ROA -2.8% · ROE -10.6% · GNPA — 68% evidence | 10.0/20 P/BV — · P/BV÷ROE — 0% evidence | 1.8/20 RS sector -24.8% · RS bench -25.9% · 1Y -20.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 5.5 + 10 + 1.8 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Robinhood Markets, Inc.HOOD | 38.6/100Mixed-negative evidence60% evidence | BREAKING OUT | 17.1/35 Income — · PAT — 26% evidence | 10.9/25 ROA 1% · ROE 6.5% · GNPA — 68% evidence | 3.4/20 P/BV 9.51× · P/BV÷ROE 1.46 70% evidence | 7.2/20 RS sector -17.2% · RS bench -18.1% · 1Y -18.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 10.9 + 3.4 + 7.2 = 38.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Houlihan Lokey, Inc.HLI | 36.3/100Mixed-negative evidence60% evidence | BASING | 14.3/35 Income — · PAT — 26% evidence | 13.8/25 ROA 2% · ROE 3.5% · GNPA — 68% evidence | 4.4/20 P/BV 4.11× · P/BV÷ROE 1.17 70% evidence | 3.8/20 RS sector -30.6% · RS bench -31.2% · 1Y -32.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.3 + 13.8 + 4.4 + 3.8 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23IREN LimitedIREN | 32.5/100Thin evidence · provisional55% evidence | ASLEEP | 16.3/35 Income 100% · PAT — 45% evidence | 4.8/25 ROA -4.9% · ROE -12.1% · GNPA — 68% evidence | 9.6/20 P/BV 4.39× · P/BV÷ROE — 10% evidence | 1.8/20 RS sector -17.2% · RS bench -18.4% · 1Y 121.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 4.8 + 9.6 + 1.8 = 32.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Circle Internet Group, Inc.CRCL | 25.7/100Adverse evidence70% evidence | ASLEEP | 12.5/35 Income 51.4% · PAT -146.2% 71% evidence | 6.6/25 ROA 0.1% · ROE 2.1% · GNPA — 68% evidence | 3.2/20 P/BV 6.89× · P/BV÷ROE 3.28 70% evidence | 3.4/20 RS sector -40.6% · RS bench -41.2% · 1Y -60.2%2 of 12 weeks ahead 70% evidence |
| Exact sum: 12.5 + 6.6 + 3.2 + 3.4 = 25.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Figure Technology Solutions, Inc.FIGR | 52.6/100Thin evidence · provisional47% evidence | ASLEEP | 23.8/35 Income 67.8% · PAT 100% 45% evidence | 13.9/25 ROA 2.4% · ROE 5.4% · GNPA — 68% evidence | 4.9/20 P/BV 5.76× · P/BV÷ROE 1.07 70% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 12 weeks ahead 0% evidence |
| Exact sum: 23.8 + 13.9 + 4.9 + 10 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Hut 8 Corp.HUT | 52.2/100Thin evidence · provisional41% evidence | FADING | 19.4/35 Income 100% · PAT — 29% evidence | 8.7/25 ROA — · ROE -18.9% · GNPA — 34% evidence | 9.8/20 P/BV 3.83× · P/BV÷ROE — 10% evidence | 14.3/20 RS sector 47.6% · RS bench 45.2% · 1Y 420.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 8.7 + 9.8 + 14.3 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Bitmine Immersion Technologies, Inc.BMNR | 35.2/100Thin evidence · provisional42% evidence | BASING | 16.2/35 Income — · PAT — 26% evidence | 6.2/25 ROA 0.2% · ROE -1.4% · GNPA — 68% evidence | 9.8/20 P/BV 0.96× · P/BV÷ROE — 10% evidence | 3.0/20 RS sector -45.2% · RS bench -45.8% · 1Y -64.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.2 + 6.2 + 9.8 + 3 = 35.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is PJT Partners Inc.'s stock price today?
PJT Partners Inc. trades at $171, −4.3% over the past year. The company is valued at $7.0 B. The stock sits at 71% of its 52-week range of $129–$188, +6.5% versus its 200-day average. On the tape, the price is topping out, 4 weeks in. — as of 5 August 2026.
What were PJT Partners Inc.'s latest quarterly results?
PJT Partners Inc. reported total income of $0.4 B and net profit of $0.1 B for the Mar 26 quarter. Income rose 31.3% and profit rose 28.6% year on year. Earnings per share were $2.21. The net margin was 21.4%, 0.5 pp lower than a year earlier. — as of 5 August 2026.
What is PJT Partners Inc.'s revenue?
PJT Partners Inc. reported revenue of $0.4 B in the Mar 26 quarter, +31.3% year on year. For the full FY25 fiscal year, revenue was $1.7 B (+14.8%). Over the last 4 years revenue compounded at 14.6% a year. — as of 5 August 2026.
What is PJT Partners Inc.'s profit?
PJT Partners Inc. earned $0.1 B of net profit in the Mar 26 quarter, +28.6% year on year — the 9th straight quarter of growth. Full-year FY25 profit was $0.3 B. The net margin ran 21.4% in the latest quarter. — as of 5 August 2026.
What is PJT Partners Inc.'s market cap?
PJT Partners Inc.'s market capitalisation is $7.0 B at a stock price of $171. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is PJT Partners Inc.'s P/BV ratio?
PJT Partners Inc. trades at a P/BV of 14.0×, at the 30th percentile of its own 5-year range, against a long-run median of 16.1×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does PJT Partners Inc. pay a dividend?
Yes — PJT Partners Inc. declared $0.25 per share for Mar 26, and $1.00 per share across the last four reported quarters. — as of 5 August 2026.
What is PJT Partners Inc.'s dividend per share?
PJT Partners Inc.'s most recently declared dividend is $0.25 per share for Mar 26, giving $1.00 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is PJT Partners Inc.'s dividend yield?
PJT Partners Inc.'s trailing dividend yield is 0.58%: $1.00 declared per share across the last four reported quarters, against a share price of $171. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is PJT Partners Inc. overvalued?
On its own history, PJT Partners Inc. looks cheap against its own history: its P/BV of 14.0× has been cheaper only 30% of the time in 5 years (long-run median 16.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is PJT Partners Inc. growing?
Yes — PJT Partners Inc. is growing: latest-quarter revenue +31.3% year on year, profit +28.6%, and the the net margin −0.5 pp at 21.4%. The 4-year compound rates are 14.6% (revenue) and 13.0% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is PJT Partners Inc. performing?
PJT Partners Inc. is topping out, 4 weeks in. Its latest quarter's income rose 31.3% and profit rose 28.6% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is PJT Partners Inc. in?
Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +47.1% at its peak to +28.0% but is still expanding, ROE lifting at 34.4%. The read comes from the last 12 quarters of growth (revenue growth +22.1% latest, profit growth +28.0% latest, eps growth +21.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is PJT Partners Inc. in an uptrend?
It is stalling — the price is topping out (week 4 of stage 3), trading +6.5% versus its 200-day average and at 71% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is PJT Partners Inc. beating the market?
On recent form, yes — PJT Partners Inc. has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +595% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.
Will PJT Partners Inc.'s stock price go up?
This page publishes no price forecast for PJT Partners Inc. What it measures instead: the stock price is $171, the price is topping out 4 weeks in. Its P/BV of 14.0× sits at the 30th percentile of its own 5-year range. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against PJT Partners Inc.?
Somewhat — short interest is 9.7% of PJT Partners Inc.'s tradable float, about 4.1 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Is PJT Partners Inc.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for PJT Partners Inc., so this page says that plainly. The cleanest available reads are revenue growth (+14.8% in FY25) and the net margin on it (21.4%) — as of 5 August 2026.
Where is PJT Partners Inc. in its business cycle?
PJT Partners Inc.'s FY25 net margin was 18.1%, against a 5-year band of 13.0%–19.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 21.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the PJT Partners Inc. story?
The sharpest disagreement: annual EPS moved +35.8% against a −4.3% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is PJT Partners Inc. a stock worth studying right now?
This is not investment advice. The machine read: PJT Partners Inc.'s earnings have outrun its stock. EPS grew +35.8% in a year against a −4.3% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.